Release Date: 30/05/13 17:21 Summary: ASX Waivers - Pro-rata, non-renounceable rights issue Price Sensitive: No Download Document 389.67KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status